FOLD Stock Ownership Activity

AMICUS THERAPEUTICS INC 13F holders

No value investing guru has made any change to the AMICUS THERAPEUTICS INC (FOLD) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying FOLD now?

According to the latest SEC filing(s) AMICUS THERAPEUTICS INC (FOLD) has not been purchased by any super investor.

To see more about who is investing in AMICUS THERAPEUTICS INC (FOLD), please go to the FOLD ownership page.

2021 Q1 (1 result)
Stephen Mandel
-100.00%
-6,678,788
-0.56%
0.00%
Current price: $9.68 58.08% Reported price*: $23.09
2020 Q4 (1 result)
Stephen Mandel
buy
+6,678,788
+0.56%
0.00%
Current price: $9.68 58.08% Reported price*: $23.09
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.